These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22999239)

  • 1. Diabetes mellitus and myocardial mitochondrial dysfunction: bench to bedside.
    König A; Bode C; Bugger H
    Heart Fail Clin; 2012 Oct; 8(4):551-61. PubMed ID: 22999239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Oxidative Stress and Mitochondrial Dysfunction in Skeletal Muscle in Type 2 Diabetic Patients.
    Diaz-Morales N; Rovira-Llopis S; Escribano-Lopez I; Bañuls C; Lopez-Domenech S; Falcón R; de Maranon AM; Sola E; Jover A; Roldan I; Diez JL; Rocha M; Hernández-Mijares A; Víctor VM
    Curr Pharm Des; 2016; 22(18):2650-6. PubMed ID: 26898744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome.
    Bugger H; Abel ED
    Clin Sci (Lond); 2008 Feb; 114(3):195-210. PubMed ID: 18184113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective role of antioxidants in diabetes-induced cardiac dysfunction.
    Vassort G; Turan B
    Cardiovasc Toxicol; 2010 Jun; 10(2):73-86. PubMed ID: 20458637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction and its impact on diabetic heart.
    Verma SK; Garikipati VNS; Kishore R
    Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1098-1105. PubMed ID: 27593695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice.
    Bonnard C; Durand A; Peyrol S; Chanseaume E; Chauvin MA; Morio B; Vidal H; Rieusset J
    J Clin Invest; 2008 Feb; 118(2):789-800. PubMed ID: 18188455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction in cardiac disease: ischemia--reperfusion, aging, and heart failure.
    Lesnefsky EJ; Moghaddas S; Tandler B; Kerner J; Hoppel CL
    J Mol Cell Cardiol; 2001 Jun; 33(6):1065-89. PubMed ID: 11444914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular bases of heart failure].
    Rodríguez Pérez JM; Gallardo GJ; Vargas Alarcón G
    Arch Cardiol Mex; 2006; 76 Suppl 4():S10-7. PubMed ID: 17469331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical prevention of cardiac remodeling and atrial fibrillation with full-spectrum antioxidant therapy and ancillary strategies.
    McCarty MF
    Med Hypotheses; 2010 Aug; 75(2):141-7. PubMed ID: 20083360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of myocardial apoptosis by alpha-lipoic acid through suppression of mitochondrial oxidative stress to reduce diabetic cardiomyopathy.
    Li CJ; Zhang QM; Li MZ; Zhang JY; Yu P; Yu DM
    Chin Med J (Engl); 2009 Nov; 122(21):2580-6. PubMed ID: 19951573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria in the diabetic heart.
    Bugger H; Abel ED
    Cardiovasc Res; 2010 Nov; 88(2):229-40. PubMed ID: 20639213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial oxidative stress and dysfunction in myocardial remodelling.
    Tsutsui H; Kinugawa S; Matsushima S
    Cardiovasc Res; 2009 Feb; 81(3):449-56. PubMed ID: 18854381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLP-1 and cardioprotection: from bench to bedside.
    Ravassa S; Zudaire A; Díez J
    Cardiovasc Res; 2012 May; 94(2):316-23. PubMed ID: 22419668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of endomyocardial biopsy in congestive heart failure in diabetics without coronary disease].
    Valensi P; Sachs RN; Nitemberg A; Perennec-Cardinali J; Attali JR
    Ann Med Interne (Paris); 1989; 140(6):473-6. PubMed ID: 2624364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mitochondrial dynamics: a potential new therapeutic target for heart failure].
    Kuzmicic J; Del Campo A; López-Crisosto C; Morales PE; Pennanen C; Bravo-Sagua R; Hechenleitner J; Zepeda R; Castro PF; Verdejo HE; Parra V; Chiong M; Lavandero S
    Rev Esp Cardiol; 2011 Oct; 64(10):916-23. PubMed ID: 21820793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria as a therapeutic target in Alzheimer's disease and diabetes.
    Moreira PI; Cardoso SM; Pereira CM; Santos MS; Oliveira CR
    CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):492-511. PubMed ID: 19702564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing heart failure in patients with diabetes.
    Srikanthan P; Hsueh W
    Med Clin North Am; 2004 Sep; 88(5):1237-56. PubMed ID: 15331315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial disease: powerhouse of disease.
    Lane N
    Nature; 2006 Mar; 440(7084):600-2. PubMed ID: 16572142
    [No Abstract]   [Full Text] [Related]  

  • 19. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.
    Doenst T; Pytel G; Schrepper A; Amorim P; Färber G; Shingu Y; Mohr FW; Schwarzer M
    Cardiovasc Res; 2010 Jun; 86(3):461-70. PubMed ID: 20035032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greater propensity of diabetic myocardium for oxidative stress after myocardial infarction is associated with the development of heart failure.
    Smith HM; Hamblin M; Hill MF
    J Mol Cell Cardiol; 2005 Oct; 39(4):657-65. PubMed ID: 16125723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.